Chronic venous insufficiency, the condition when blood doesn’t travel from the legs back to the heart properly, results in skin changes, painful ulceration, can cause problems with leg swelling, and can be associated with varicose veins.
A common condition that affects nearly 24 percent of adults, treatment for chronic venous insufficiency is currently limited to compression stockings and wound care.
Now a catheter-based therapy treatment is gaining legs.
Bay Area startup InterVene Inc. just raised a $5.9 million Series A round backed by Boston Scientific and a number of other investors including North Texas Angels Network, Green Park and Golf Ventures, Launch Capital, and a syndicate of angels.
This funding will support a two-stage clinical trial. If the trial shows that the treatment method works safely and effectively, those with chronic venous insufficiency will have a new therapy treatment option to look forward to for managing this condition.
InterVene explains that the catheter-based therapy will work as follows, “InterVene’s minimally invasive approach creates venous leaflets from the intima – the innermost layer of the vein wall – while leaving the outermost layers intact. These leaflets function as one-way valves, restoring normal venous pressure and preventing blood from pooling in the legs. This percutaneous technique is predicated on an open surgical procedure, The Maleti Neovalve.”
Need treatment for chronic venous insufficiency, varicose veins, spider veins, or any other vein treatments? Contact Austin Vein Specialists to schedule an appointment with one of the Board Certified Vein Specialists to discuss the best available modern treatment that is right for you. Call 512-220-5401 today!
